GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BGLAF) » Definitions » Cash per Share

BGLAF (BioGaia AB) Cash per Share : $1.08 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). BioGaia AB's Cash per Share for the quarter that ended in Sep. 2024 was $1.08.


BioGaia AB Cash per Share Historical Data

The historical data trend for BioGaia AB's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Cash per Share Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 1.74 1.62 1.42 1.49

BioGaia AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 1.49 1.51 0.95 1.08

BioGaia AB Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

BioGaia AB's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

BioGaia AB's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioGaia AB  (OTCPK:BGLAF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


BioGaia AB Cash per Share Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

From GuruFocus

Q3 2019 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2021 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2024 Biogaia AB Earnings Call Transcript

By GuruFocus News 10-23-2024

Q3 2022 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2023 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2019 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2020 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2023 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024